Notice Number: NOT-OD-14-082
Release Date: April 22, 2014
The National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ) announce clarifications to policy on application submissions that was updated recently (NOT-OD-14-074).
On April 17, 2014 the NIH and AHRQ announced a change in policy on application submissions (NOT-OD-14-074):
"Effective immediately, for application due dates after April 16, 2014:
All of the provisions of the updated submission policy in NOT-OD-14-074 remain in effect. Clarifications are provided below for certain key points that were raised in questions we received.
Questions were received that asked whether a new (A0) application, following an unsuccessful resubmission (A1) application, could be submitted only for the next, appropriate due date. To clarify, following an unsuccessful resubmission (A1) application and release of the summary statement, an applicant may submit the same idea as a new (A0) application for any due date in the future that is appropriate for the grant mechanism and Funding Opportunity Announcement (FOA).
Questions were received asking which grant programs fall under the policy. To clarify, the updated policy applies to major types of applications and activity codes - including applications for research grants, the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, Career Development Awards, Individual Fellowships, Institutional Training Grants, Resource Grants, Program Projects, and Center Grants.
The updated policy allows an investigator to submit a new (A0) application following an unsuccessful resubmission (A1) application. Subsequent questions asked whether a time limit exists between an unsuccessful resubmission (A1) application and the subsequent new (A0) application, whether the number of such cycles is limited, and whether an intervening resubmission (A1) application is required in order to submit a new (A0) application again.
Please see resubmission FAQs for answers to many common questions.
Please direct all inquiries to:
Division of Receipt and Referral
NIH Center for Scientific Review
NIH Review Policy Officer
Dr. Gerald (Jerry) Calderone
AHRQ Referral Officer
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.